Zastosowanie antagonisty receptorów NMDA (N-metylo-D-asparaginianu) – ketaminy w leczeniu depresji lekoopornej Journal title: Psychiatria Polska Authors: Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, Łukasz Święcicki Subject(s):
Involvement of prolactin and somatostatin in depression and the mechanism of action of antidepressant drugs. Journal title: Pharmacological Reports Authors: Agata Faron-Górecka, Maciej Kuśmider, Joanna Solich, Magdalena Kolasa, Kinga Szafran, Dariusz Zurawe... Subject(s):
Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression Journal title: Psychiatria Polska Authors: Paweł Gosek, Magdalena Chojnacka, Przemysław Bieńkowski, Łukasz Święcicki Subject(s):
Chronic Fatigue Syndrome: Diagnostic Enigma Journal title: Journal of Advances in Medicine and Medical Research Authors: Pallavi Nadkarni Subject(s):
Decreased Hippocampal Volume is Related to White Matter Abnormalities in Treatment-Resistant Depression Journal title: International Journal of Brain Disorders and Treatment Authors: Subject(s):
Molecular Modeling of the antagonist compound esketamine and its molecular docking study with non-competitive N-methyl-D-aspartate (NMDA) receptors NR1, NR2A, NR2B and NR2D Journal title: Progress in Chemical and Biochemical Research Authors: Mehdi Nabati, Vida Bodaghi-Namileh, Saman Sarshar Subject(s): Biology, Information Science & Library Science, Social Sciences, Interdisciplinary, Humanities, Multidisciplinary, Education & Educational Research, Physics, Multidisciplinary, Agriculture, Multidisciplinary, Education, Scientific Disciplines, Psychology, Educational, Education, Special
